BRIUX | CIRRX | BRIUX / CIRRX | |
Total Expense Ratio | 0.80 | 1.25 | 64% |
Annual Report Gross Expense Ratio | 0.90 | 1.25 | 72% |
Fund Existence | 8 years | 11 years | - |
Gain YTD | 2.256 | 4.188 | 54% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 260M | 8.35B | 3% |
Annual Yield % from dividends | 1.69 | 2.37 | 71% |
Returns for 1 year | 5.45 | -2.00 | -272% |
Returns for 3 years | 45.48 | 32.19 | 141% |
Returns for 5 years | 41.64 | 26.81 | 155% |
Returns for 10 years | N/A | 54.80 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NECCX | 14.82 | 0.02 | +0.14% |
Natixis US Equity Opportunities C | |||
JFNSX | 70.08 | N/A | N/A |
Janus Henderson Global Life Sciences S | |||
VMCPX | 396.31 | N/A | N/A |
Vanguard Mid Cap Index InstitutionalPlus | |||
BGLAX | 14.91 | N/A | N/A |
Brookfield Global Listed InfrastructureA | |||
BRWRX | 27.40 | N/A | N/A |
MFS Blended Research Growth Eq R1 |